electroCore

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell electroCore and other ETFs, options, and stocks.

About ECOR

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems.

CEO

Daniel S. Goldberger

CEODaniel S. Goldberger

Employees

Employees52

Headquarters

Rockaway, New Jersey

HeadquartersRockaway, New Jersey

Founded

2005

Founded2005

Employees

Employees52

ECOR Key Statistics

Market cap

25.11M

Market cap25.11M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

298.87K

Average volume298.87K

High today

$0.38

High today$0.38

Low today

$0.34

Low today$0.34

Open price

$0.38

Open price$0.38

Volume

468.82K

Volume468.82K

52 Week high

$0.98

52 Week high$0.98

52 Week low

$0.195

52 Week low$0.195

ECOR Earnings

-$0.11

-$0.07

-$0.04

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 9, After Hours

ActualExpected Mar 9, After Hours

electroCore

Why Robinhood?

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. Show more

ECOR Key Statistics

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems.